Everest Medicines lures Roche exec to its board as CCO

Shanghai and Beijing-based biopharma firm Everest Medicines, which addresses critical unmet medical needs for patients in Greater China and other parts of Asia, has appointed pharmaceutical industry veteran Wende Chen as its chief commercial officer.

Mr Chen will also serve as an operating partner for CBC Group, formerly known as C-Bridge Capital, the company’s founding investor.

In his new role, Mr Chen will establish and execute commercialization strategies and plans across Everest Medicines’ portfolio of therapeutic products. He will lead all aspects of global sales, channel and alliance strategies and manage commercial partnerships and opportunities.